Susi Geiger

Susi Geiger was educated in Germany, France and Ireland. Her research investigates the organisation of pharmaceutical markets and pharmaceutical pricing issues. She is involved in various policy activities to rethink pharmaceutical markets. She is a member of the WHO Technical Advisory Group on Pharmaceutical Pricing Policies and she is the ERC Ambassador for Ireland. Susi is active in the access to medicines movement and she’s been a member of Access to Medicines Ireland since 2018. She also sits on several editorial boards of international journals and three Scientific Advisory Boards. She was a Visiting Scholar at the Universities of California, Berkeley, University of Auckland, École Nationale Supérieure des Mines de Paris (MINES ParisTech), Stockholm School of Economics, University of Vienna, Weizenbaum Institute Berlin, University of Copenhagen, and others. Susi has held prestigious grants totalling over €10m institutional grants. As the only-ever Irish female business scholar, she was awarded a highly prestigious €2 million ERC (European Research Council) Consolidator Grant. Her work has appeared in over 80 international peer-reviewed journal publications (16 FT50/ABS4 publications) and 120 conference publications. Her current book “Peak Pharma: Toward a New Political Economy of Health” (Oxford Univ. Press 2025) draws up a vision of pharmaceutical commons that is geared toward the public good rather than profit maximization.